The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.
The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.
AI solutions are on the rise throughout healthcare – and both payers and health systems are aiming to deploy these technologies as a way to help increase meaningful engagement with […]
Chief Digital Officers, or CDOs, are an emerging position in healthcare. As the emphasis on digital health increases, their responsibilities are taking on increased significance, with some industry leaders even […]
Your patients face a host of both external and internal barriers that keep them from scheduling and showing up for mammogram appointments — barriers that can change unexpectedly. To help healthcare organizations increase women’s health screenings, Lirio offers a Precision Nudging™ solution that moves patients to schedule and attend mammogram appointments.